Mesenchymal stem cells (MSCs) have demonstrated the ability to differentiate into a number of different cells; they also demonstrate immunomodulatory properties that have great potential for use as a stem cell-based therapeutic treatment option and for the treatment of autoimmune diseases – including rheumatoid arthritis (RA).
RA is a chronic and debilitating inflammatory disorder that not only affects the joints, muscles, and tendons, but also damages a number of other body systems, including the eyes, skin, lungs, heart, and blood vessels. It is estimated that roughly 1.5 million Americans are afflicted by RA. While the exact cause of RA is not yet fully understood, the condition is one of over 80 known autoimmune diseases occurring as a result of the immune system mistakenly attacking the body’s own healthy tissue.
Current treatment of RA primarily involves the use of steroids and antirheumatic drugs used primarily to manage associated symptoms of the condition, rather than treat the condition itself. These drugs are also commonly associated with a number of unwanted side effects with users often developing resistance to the medication after prolonged use.
Considering the relative ineffectiveness of drugs designed to treat RA and RA-associated symptoms, scientists have turned to investigate the use of MSC-based therapy as a potential treatment for RA.
As part of this investigation, Sarsenova et al. examined both conventional and modern RA treatment approaches, including MSC-based therapy, by examining the connection between these stem cells and the innate and adaptive immune systems. This review also evaluates recent preclinical and clinical approaches to enhancing the immunoregulatory properties of MSCs.
Through a number of in vitro studies, researchers have realized that MSCs have the ability to inhibit the proliferation of effector memory T cells which, in turn, prevents the proliferation of inflammatory cytokine production. Additionally, these studies have also demonstrated that MSCs are able to modulate functions of the innate immune system by inducting the inflammatory process and activating the adaptive immune system.
Preclinical studies have demonstrated the ability of MSCs to suppress inflammation both through interactions with cells of the immune system and through paracrine mechanisms. This has been demonstrated to be very important as cells of the innate immune system have been shown to have an important role in both the development and progression of RA.
While a number of clinical studies evaluating the effectiveness of MSC-based therapies for the treatment of RA were still ongoing at the time of publication, the nine completed studies primarily demonstrated that using MSCs for the treatment of RA is safe, well tolerated in both the short and long-term, and provides clinical improvements in RA patients.
Despite the many positive and promising outcomes observed through these clinical trials, the authors of this review also point out some limitations associated with the treatment of RA with MSCs. These limitations include many of the referenced studies lacking a placebo control, low enrollment in some studies, and a lack of optimal protocol (for both MSC sourcing and route of administration) for RA treatment with MSCs.
Considering these limitations, Sarsenova et al. point out the need for more well-defined and effective therapeutic windows for the treatment of RA with MSCs, including MSC priming to promote an anti-inflammatory phenotype, in a future study as a way to better understand the perceived benefits of a stem-cell therapy for the treatment of RA and other autoimmune diseases.
The chronic inflammatory disorder rheumatoid arthritis (RA) affects the joint lining, causing painful swelling. Since there is not yet a permanent cure for the condition, the treatment goal is to put a patient’s RA into remission, where the symptoms are well controlled.
RA remission is more complicated than it seems, and there are many vital facts to know if you have RA.
1. Remission Doesn’t Mean “Without Symptoms”
The Arthritis Foundation defines remission as having limited symptoms of the condition. Since this definition can be subjective, researchers have developed criteria to use in clinical trials. These remission criteria include:
Only one or fewer swollen joints
Only one or fewer tender joints
The patient assesses arthritis activity as a one or less on a 0–10 scale
A blood test evaluating inflammation shows little to no inflammation
If any of these criteria aren’t met, a patient is not in remission.
2. Remission Can Last for Any Length of Time
Some patients with RA experience remission for a few weeks, and others for a year or longer. There is no guarantee that remission will last for a specific duration.
3. Early Treatment Increases Odds of Remission
While RA symptoms need to persist for six weeks for a doctor to diagnose the condition, the sooner the inflammation is controlled, the better your chances of achieving remission. Since inflammation from RA can cause long-term changes in the joints, patients need aggressive treatment to get the condition under control.
While some patients may be able to cut back on their medication while their RA is in remission, for others, that will cause a relapse. Medication adjustments require your doctor’s guidance to maintain control over your symptoms.
6. Relapses Are Unavoidable
Unfortunately, almost all patients who go into RA remission experience a relapse at some point. If you’ve experienced a flare-up after remission, schedule an appointment with your physician immediately so you can make any necessary adjustments to your treatment plan.
Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disorder that causes your immune system to mistakenly attack its own tissue and specifically affects the lining of the joints, resulting in painful swelling, bone erosion, and eventually permanent joint deformity.
With an estimated 1.5 million people in the U.S. living with RA, the disease affects nearly three times as many women as men. In addition to affecting the synovial joints and causing articular destruction and functional disability, an estimated 40% of those diagnosed with RA experience additional signs and symptoms that do not involve the joints; these affected areas often include most body systems and specifically the skin, eyes, lungs, nerves, heart, and blood vessels.
Multiple studies have demonstrated that bone marrow mesenchymal stem cells could be effective for treating a number of autoimmune diseases, including RA. However, little is known about the effectiveness of umbilical cord (UC)-MSCs as they relate to the treatment of autoimmune diseases, specifically RA.
Considering this, it comes as little surprise to learn that bone marrow MSCs (BM-MSCs) have been the most common source of MSCs used in the study of immunosuppression of autoimmune conditions. However, the collection of BM-MSCs requires aspiration, which is an invasive procedure. Additionally, the number of BM-MSCs and the differentiating potential of BM-MSCs both decrease significantly with age.
UC-MSCs, on the other hand, are collected using non-invasive procedures after birth and before the umbilical cord is discarded. Additionally, UC-MSCs have been well documented to possess properties of self-renewal and multipotent differentiation, making them a potential candidate for alternative sources of stem cells.
In this study, Liu et al. examined the suppressive effects of UC-MCSs on the proliferation, invasive behavior, and inflammatory responses of fibroblast-like synoviocytes (FLSs) from patients with RA.
At the conclusion of this study, the authors offered a number of key findings about the effectiveness of UC-MSCs in this application, including:
US-MSCs inhibited proliferation of FLSs from RA patients
US-MSCs suppressed the invasive behavior and MMP expression of FLSs from RA patients
US-MSCs suppressed the inflammatory response of FLSs from RA patients
UC-MSCs induced hyporesponsiveness of T lymphocytes from RA patients
UC-MSCs induced Tregs from RA patients
UC-MSCs prevented tissue damage and reduced inflammatory responses in CIA
The authors conclude by indicating the evidence provided by this study indicates that UC-MSCS can exert a profound inhibitory effect on FLSs and T cells from RA patients and that they might be a therapeutic perspective in RA. Source: “Therapeutic potential of human umbilical cord mesenchymal stem ….” https://pubmed.ncbi.nlm.nih.gov/21080925/.
Do you suffer from aches and pains due to rheumatoid arthritis (RA)? The stiffness caused by RA is a nuisance for many patients and it is especially prevalent in the morning. When you awake from even the most comfortable of sleep, your joints may feel painful and stiff for several hours. How can this be avoided?
4 Ways to Reduce Morning Stiffness for RA Patients
Most patients turn to over-the-counter pain medications to ease their RA morning stiffness, but there may be some other alternatives. The following are four ways to reduce rheumatoid arthritis stiffness and start your day off right.
1. Turn Up the Heat
Experts suggest turning your heat up about 30 minutes before you plan to start your day. This will allow time for your joints to warm up and feel less stiff while you take it easy and relax in bed or have your morning coffee. By the time you need to get ready and head out the door, your body will feel more relaxed, and stiffness may be decreased.
2. Take Medication as Soon as You Wake Up
While you’re turning up the heat, go ahead and take any of your rheumatoid arthritis medications. You want to give your medication time to kick in and take effect before you begin your morning routine. This will help ease most of the aches and pains that you may feel in your joints during morning activities.
3. Practice Gentle Movements
Once you are ready to get out of bed, practice gentle movements rather than jumping to your feet and rushing around the house. Simple range-of-motion exercises can help stretch your muscles and loosen joints in the hands, wrists, and feet.
4. Take A Hot Shower
While many people opt for nighttime showers, RA patients may benefit from taking a hot morning shower. Taking a warm shower upon waking in the morning will help loosen and relax the joints, decreasing any stiffness or aching.
If you suffer from chronic pain from your rheumatoid arthritis, you may want to explore how regenerative medicine, also known as stem cell therapy, may help manage symptoms. In addition, some patients are discovering help from peptides. These are chains of amino acids, and some may have the potential for those with chronic pain. Alternative medicine does not offer a cure, but for some, it may help improve quality of life.
There are a number of things that can cause arthritis, a painful condition that causes stiffness in joints. In Rheumatoid Arthritis (RA), the body’s immune system attacks the musculoskeletal system, causing inflammation that leads to arthritis pain. Over time, RA can cause a number of problems, including cartilage deterioration, swelling, and excess synovial fluid at the joint. In this article, we talk about how Stem Cell Therapy can help to treat Rheumatoid Arthritis.
Using Stem Cell Therapy to Treat Rheumatoid Arthritis
Because RA is a chronic condition, there is no cure. This means that treatment focuses on preventing attacks and easing symptoms. While there are medications that can help to tamp down the autoimmune response that causes RA pain, symptom management tends to rely on medication to relieve pain, which can be difficult to moderate.
Instead, some patients are seeking out stem cell therapy. Stem cells have the ability to differentiate into other cell types. By administering mesenchymal stem cells (MSCs) systemically and directly to problematic joints, it may potentially help to regrow cartilage tissue and ease pain from rheumatoid arthritis.
How Stem Cell Therapy Can Benefit RA Patients
By taking a different approach to the treatment of RA, stem cell therapy offers potential relief that traditional treatments have not been able to provide to patients, including:
Because stem cells are able to differentiate into other cell types, they can be particularly useful for patients suffering from RA. When these stem cells are injected into a joint, they can help to rebuild the cartilage that cushions joints, counteracting the damage from RA.
Stem cells also have the potential to help regenerate other damaged tissues as well, including the synovium tissues, which help lubricate joints to keep them from becoming inflamed.
Regulating the Autoimmune Response
Stem cells have shown to be safe and promising in helping reduce the inflammatory response that results from the autoimmune attacks behind RA. Stem cell therapy has been used in the treatment of other autoimmune diseases, including Crohn’s disease and multiple sclerosis, and it shows promise for RA, as well. So yes, Stem Cell Therapy can help to treat Rheumatoid Arthritis.
Reducing Further RA Damage
Stem cell therapy offers the possibility of reducing further RA attacks on joints that may not yet be affected by the disease. With the potential to limit the autoimmune responses that cause RA damage and to instead encourage healing and tissue growth, stem cells may be able to slow the impact of rheumatoid arthritis. This may allow patients to experience less pain and preserve their quality of life. If you would like to schedule an appointment to treat your RA, contact a care coordinator today!
Arthritis is characterized by inflammation in the joints, which often causes pain, stiffness, and swelling. The levels of inflammation in your body are influenced by a number of factors, including diet. Some foods in particular have been shown to increase inflammation, thus exacerbating arthritis symptoms. To help control your arthritis, here are some foods to limit or avoid.
The oil used for frying often contains omega-6 fatty acids, which have been linked to increased inflammation. Because they’re associated with a number of other health issues, including heart problems, they’re best avoided altogether.
Salt is found in many different foods, but it’s important for people with arthritis to control their consumption. The mineral can increase the body’s inflammatory response, and it’s also been associated with an elevated risk of rheumatoid arthritis (RA). Flavor your food with joint-healthy seasonings, such as cumin, ground pepper, or garlic powder, instead.
Added sugars have a broad range of health risks, ranging from their association with obesity and type 2 diabetes to elevated inflammation. Even low to moderate intake of sugary drinks such as sodas, juices, and sweet teas has been linked to heightened inflammation. If plain water seems too bland, considering adding a fresh wedge of lemon or cucumber slices to give it some flavor.
Moderate alcohol intake can reduce inflammation in certain types of arthritis. For instance, the antioxidants in red wine help to promote joint health in RA with a daily five-ounce serving. Yet, alcohol can also trigger symptoms in other types of arthritis, including gout. If you’re unsure about how drinking could affect your arthritis, it’s best to talk to your rheumatologist.
Red meat is notoriously high in saturated fat, which has been linked to inflammation that leads to joint swelling. Other types of protein, including plant-based sources and poultry, are lower in saturated fats, and thus better for joint health.
High-Fat Dairy Products
Like red meat, full-fat dairy products, including cheese, yogurt, and milk, have high levels of fat. They also typically contain more added sugars than low-fat varieties. Some people with arthritis eliminate dairy from their diets altogether to reduce its inflammatory effects, while others enjoy low-fat options. Low-fat yogurt, in particular, may be worth keeping in your diet, as it contains probiotics which can actually help control inflammation.
Heavily Processed Foods
Heavily processed foods such as refined carbohydrates, candy, lunch meat, and baked goods often have additives that contribute to inflammation. Many are loaded with added sugars or excess salt, and can therefore aggravate arthritis symptoms. Whenever possible, choosing primarily whole foods such as fruit, vegetables, healthy fats, and lean protein, will be best for controlling inflammation and arthritis symptoms.
This website and its contents are not intended to treat, cure, diagnose, or prevent any disease. Stemedix, Inc. shall not be held liable for the medical claims made by patient testimonials or videos. They are not to be viewed as a guarantee for each individual. The efficacy for some products presented have not been confirmed by the Food and Drug Administration (FDA).
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.